Abstract
These comments are minor modifications to the material submitted by the author to the docket for the FDA Pharmacy Compounding Committee that met on October 15 and 16, 1998.
PDF download + Online access
Issue Purchase
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.
Register now or learn more